[ad_1]
Dandy Pharmatech, an investment of Donggu Bio Pharma, attracted about 40 billion won in investments
FierceBiotech, a US pharmaceutical journal, is a start-up owned by Dandy PharmaTech, a development company of Drugs based at Johns Hopkins University,
This Series A investment includes D & D PharmaTech, Smilegate Investment, Intervest, LB Investment, and Magma Investment, which invested $ 36 million to develop treatments for cancer. Parkinson's disease and neurodegenerative diseases. , Zeon Investment and Dong-gu Bio Pharmaceuticals.
Founded in 2016, New Raleigh belongs to Dandy Pharmatech, a bio-based business founded by Dr. Ted Dawson, a degenerative brain disease physician, Johns Hopkins University School of Medicine. . Neurali is currently developing NLY1, a neuropathic peptide treatment, such as Parkinson's or Alzheimer's.
Currently, there is no basic treatment for preventing neurological diseases such as Parkinson's disease or Alzheimer's disease.
NYL1 has shown an unprecedented effect compared to existing treatments, "said Victor Rosie, co-founder of Neuralli.
"I am waiting to be a pioneering treatment for Parkinson's disease."
[사진=gettyimagesbank.com]
[관련기사]
☞ Three Tips for Retrieving Female Sexuality [Étude]
☞ Two Things You Should not Do When You Wake Up at Night
☞ If You're Eating Yogurt, ☞ ☞ ☞ ☞ ☞ The body that suffered heat, good food for lovers 4
Source link
